Impact of fetal or child loss on parents’ perceptions of non-invasive prenatal diagnosis for autosomal recessive conditions

Pisnoli, Laura; O’Connor, Anita; Goldsmith, Lesley; Jackson, Leigh; Skirton, Heather

doi:10.1016/j.midw.2015.12.009

Cited by 5 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although work has been undertaken to gauge the attitudes of the general public toward genetic screening, far less attention has been paid to the views of families with experience of the conditions for which screening could be offered, with a few notable exceptions [Skinner et al, ; Maxwell et al, ; Pisnoli et al, ]. However, affected families represent an important stakeholder group; such families possess expert “experiential knowledge” [Abel and Browner, ; Boardman, , ] of the condition in question and unparalleled insight into the realities of its day‐to‐day impact.…”

Section: Introductionmentioning

confidence: 99%

Population screening for spinal muscular atrophy: A mixed methods study of the views of affected families

Boardman

Young

Griffiths

2016

American J of Med Genetics Pt A

View full text Add to dashboard Cite

Autosomal recessive conditions are a significant health burden with few treatments. Population carrier screening has been suggested as a means to tackle them. Little is known about the views of affected families despite the potential for direct impacts on them. Data are presented on attitudes among families affected by Spinal Muscular Atrophy (SMA) toward two population screening programs, pre‐conception, and prenatal. Data were gathered through qualitative interviews (n = 36) and a survey (n = 337). Eighty‐two survey participants had SMA and 255 were family members. The majority were in favor of screening (75%). Reasons for supporting pre‐conception screening support were a belief that it would reduce SMA‐related terminations and raise awareness of SMA in the population. For prenatal screening, reasons for support included a belief in the importance of informed decision‐making and the need to reduce suffering. Key reasons for non‐support of pre‐conception screening included concerns about carrier stigmatization and social engineering. For prenatal screening, concerns focused on the collateral loss of high quality of life lives affected by SMA. This study highlights that those affected by SMA are predominantly in favor of screening, although pre‐conception screening is most favored. While family members and adults with SMA had largely consistent views, perceptions varied according to the severity (type) of SMA, with those affected by SMA type II the least likely to support screening. These findings suggest that screening for SMA is a complex issue for affected families, underscoring the need to consider and include their views when planning and implementing screening programs. © 2016 Wiley Periodicals, Inc.

show abstract